DFM STUDENT SYLLABUS - Flipbook - Page 51
Clinical Integration: Combining Lymphocyte MAP™ with Other Testing
601
Complementary Cyrex Arrays
602
Array 2: Intestinal Antigenic Permeability Screen
602
Array 5: Multiple Autoimmune Reactivity Screen
602
Array 10-90: Multiple Food Immune Reactivity Screen
602
Array 11: Chemical Immune Reactivity Screen
602
Comprehensive Immunological Assessment
602
Inflammatory Markers
602
Oxidative Stress Assessment
602
Viral Serology
602
Functional Assays
603
Related Physiological Systems
603
HPA Axis Assessment
603
Microbiome Analysis
603
Nutrient Status
603
Toxin Burden
603
Monitoring and Follow-up: Tracking Immune System Changes
603
Baseline Assessment
604
Identifying Primary Imbalances
604
Establishing Severity
604
Guiding Initial Interventions
604
Intervention Monitoring
604
Expected Timeline for Improvement
604
Refined Treatment Approach
604
Long-term Surveillance
604
Early Detection of Relapse
605
Preventive Strategy Adjustment
605
Age-Related Changes
605
Future Directions: Emerging Applications of Lymphocyte Analysis
605
Expanded Marker Panels
605
Exhaustion Markers
605
Senescence Markers
605
Functional Activation Markers
606
50
